Two Sigma Investments’s Exelixis EXEL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q4
Sell
-13,000
Closed -$275K 4445
2021
Q3
$275K Buy
+13,000
New +$241K ﹤0.01% 3735
2020
Q2
Sell
-17,900
Closed -$308K 3103
2020
Q1
$308K Buy
+17,900
New +$327K ﹤0.01% 2284
2019
Q3
Sell
-10,200
Closed -$218K 3557
2019
Q2
$218K Buy
+10,200
New +$214K ﹤0.01% 3044

Other funds holding EXEL

Two Sigma Investments's EXEL Position: Q1 2026 in Review

Two Sigma Investments increased its Exelixis (EXEL) stake by 706% in Q1 2026, buying an estimated $83.1M and bringing the position to 2,206,212 shares worth $94.6M. The position accounts for 0.08% of the portfolio, ranked #290.

Two Sigma Investments first reported a position in EXEL in Q1 2014 and has held it in 37 quarters since. 695 funds tracked by Wall St. Rank hold EXEL as of Q1 2026.

  • Two Sigma Investments held 2,206,212 shares of Exelixis worth $94.6M as of Q1 2026.
  • Two Sigma Investments bought 1,932,421 Exelixis shares in Q1 2026, an estimated $83.1M.
  • Exelixis made up 0.08% of Two Sigma Investments's portfolio in Q1 2026, its #290 holding.
  • Two Sigma Investments first reported a position in Exelixis in Q1 2014 and has held it in 37 quarters since.
  • 695 funds tracked by Wall St. Rank held Exelixis as of Q1 2026.

Based on Two Sigma Investments's 13F filing for Q1 2026, filed 15 May 2026.